Glympse Bio raises more than $46M in Series B round for biosensor technology
The company is developing biosensors, initially for NASH, that could be used in place of liver biopsy and have applicability in development of drugs for the disease.
QurAlis raises $42M in Series A round to develop therapies for ALS
Startup companies that have raised closed funding rounds in the past week also include C2N Diagnostics, Carbon Health, Stellar Health and Modulus Discovery.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.